Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5578317 | 0.85 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL28393985 | 0.82 | GLO1 (0.40) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL22213844 | 0.81 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL27462161 | 0.81 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL9723930 | 0.81 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL60410 | 0.80 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL6674982 | 0.80 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL10966369 | 0.80 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL1088298 | 0.80 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL6676758 | 0.80 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10NPSR1GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 453 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125513-A1 | CURABLE RESIN COMPOSITIONS | ILLUMINA INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4405750-B1 | CURABLE RESIN COMPOSITIONS | ILLUMINA INC (US) | 2026-04-22 | — | — | EP | claimed |
| US-12559627-B2 | Curable resin compositions | ILLUMINA, INC. (US) | 2026-02-24 | — | — | US | claimed |
| WO-2025111523-A1 | METHODS OF FORMING CATIONIC POLYMERS USING INITIATORS ACTIVATED ONLY BY ULTRAVIOLET LIGHT | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | claimed |
| US-20250163190-A1 | METHODS OF FORMING CATIONIC POLYMERS USING INITIATORS ACTIVATED ONLY BY ULTRAVIOLET LIGHT | SOLENIS TECHNOLOGIES, L.P. (US) | 2025-05-22 | — | — | US | claimed |
| CN-118496783-A | UV (ultraviolet) viscosity reducing adhesive as well as preparation method and application thereof | 南京大学 | 2024-08-16 | — | — | CN | claimed |
| EP-4405749-A2 | CURABLE RESIN COMPOSITIONS | Illumina, Inc. (US) | 2024-07-31 | — | — | EP | claimed |
| EP-4405750-A1 | CURABLE RESIN COMPOSITIONS | Illumina, Inc. (US) | 2024-07-31 | — | — | EP | claimed |
| CN-117813549-A | Curable resin composition | 因美纳有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117813553-A | Curable resin composition | 因美纳有限公司 | 2024-04-02 | — | — | CN | claimed |
| WO-2003088956-A1 | METHOD FOR TREATING ILEUS WITH AN ALPHA -KETOALKANOIC ACID OR - ESTER OR - AMIDE | CRITICAL THERAPEUTICS, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| US-20030073743-A1 | Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion | XANTHUS LIFE SCIENCES, INC. (CA) | 2003-04-17 | — | — | US | claimed |
| WO-2002074301-A1 | METHOD OF USING PYRUVATE AND/OR ITS DERIVATIVES FOR THE TREATMENT OF CYTOKINE-MEDIATED INFLAMMATORY CONDITIONS | UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2002-09-26 | — | — | WO | claimed |
| EP-1233767-A1 | PYRUVATE ESTER COMPOSITION AND METHOD OF USE FOR RESUSCITATION AFTER EVENTS OF ISCHEMIA AND REPERFUSION | Xanthus Life Sciences, Inc. (CA) | 2002-08-28 | — | — | EP | claimed |
| EP-0912467-B1 | ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE | RHODIA CHIMIE SA (FR) | 2002-04-24 | — | — | EP | claimed |
| WO-2001024793-A1 | PYRUVATE ESTER COMPOSITION AND METHOD OF USE FOR RESUSCITATION AFTER EVENTS OF ISCHEMIA AND REPERFUSION | XANTHUS LIFE SCIENCES, INC. (CA) | 2001-04-12 | — | — | WO | claimed |
| EP-0211667-B1 | RADIATION-SENSITIVE RESIN COMPOSITION | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1992-03-11 | — | — | EP | claimed |
| EP-0457367-A1 | Radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-11-21 | — | — | EP | claimed |
| US-4891435-A | Preparation of 4,4-dimethyltetrahydrofuran-2,3-dione | BASF AKTIENGESELLSCHAFT (DE) | 1990-01-02 | — | — | US | claimed |
| EP-0211667-A2 | Radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1987-02-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559627-B2 | Curable resin compositions | PSMB2, ECPAS, RPS26 | ALDH1A1 3100/4885LMNA 2734/4885HSD17B10 4429/4885 |
| US-20260125513-A1 | CURABLE RESIN COMPOSITIONS | RAD51, ACR, ACMSD | ALDH1A1 562/4885LMNA 3135/4885HSD17B10 2675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.